LBBW Venture Capital

Corporate VC Stuttgart, Germany · Founded 1998

LBBW Venture Capital targets early-stage disruptive IT and life science companies across the DACH region, focusing on software-driven technologies and innovations in drug development, diagnostics, medical devices, and healthcare IT.

About LBBW Venture Capital

LBBW Venture Capital is the venture arm of Landesbank Baden-Wurttemberg, a German regional bank, investing in technology companies with a focus on the DACH region, particularly Germany, Austria, and Switzerland. The fund writes initial checks of roughly EUR 1M to EUR 5M from Series A through B, typically as a co-investor with selective lead capacity, and operates with longer time horizons than typical VC funds given its bank-affiliated capital base. Healthcare exposure is partial and concentrated in digital health, healthcare IT, and selectively medtech, with the firm comfortable looking at AI-enabled software where it has a clear DACH market angle. AI focus is welcome but not a primary thesis. Founders best suited are Series A and B German, Austrian, or Swiss CEOs in digital health or healthcare IT with a clear DACH go-to-market plan, who would benefit from a regionally-connected investor with bank-affiliated relationships and longer hold periods than typical VC. Founders who do not fit include US-only digital health teams, therapeutics, capital-intensive devices, and consumer wellness without an enterprise buyer. Geographic preference is DACH with selective exposure to other parts of Europe. The entry path is warm introduction through a German operator, a Stuttgart-area banker, a portfolio CEO, or a co-investor at funds like Heal Capital, High-Tech Grunderfonds, or Earlybird. LinkedIn outreach to a partner with a focused DACH market summary is a reasonable secondary option. Expect deliberate, evidence-driven diligence and a partner that values commercial fundamentals and regional fit.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by LBBW Venture Capital

Tools made by companies in LBBW Venture Capital's portfolio that we cover in the directory.

Nextiva
Nextiva
Patient Engagement & Education
Nextiva is a UCaaS provider offering HIPAA-compliant VoIP, SMS, video meetings, and team chat, suitable for mid-sized healthcare organizations. Its AI-powered platform helps streamline patient operations, reduce costs, and improve patient outcomes through features like automated scheduling, prescription refills, and FAQ handling.

Portfolio companies in our directory

Other portfolio companies

Companies in LBBW Venture Capital's portfolio not currently in our directory.

Team

Andreas von Richter
Managing Director
Dr. Frank Mu00fchlenbeck
Managing Director
Caroline Lehmann
Senior Investment Manager
Dr. Patrick Herlinger
Senior Investment Manager
Maximilian Naumow
Senior Investment Manager

Pitch / review this investor

Have you raised from LBBW Venture Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.